Diabetes Research and Clinical Practice
Volume 75, Issue 3 , Pages 327-332 , March 2007

The significance of tumor necrosis factor-α in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment

  • Haibing Chen

      Affiliations

    • Shanghai Diabetic Institute, Shanghai Jiaotong University Affiliated No. 6 People Hospital, 600 Yishan Road, Shanghai 200233, China
    • ,
  • An Ren

      Affiliations

    • Department of Endocrine & Metabolism, AnHui Provincial Hospital, HeFei, Anhui, China
    • ,
  • Shilian Hu

      Affiliations

    • Department of Endocrine & Metabolism, AnHui Provincial Hospital, HeFei, Anhui, China
    • ,
  • Weilin Mo

      Affiliations

    • Department of Endocrine & Metabolism, AnHui Provincial Hospital, HeFei, Anhui, China
    • ,
  • Xuenong Xin

      Affiliations

    • Department of Endocrine & Metabolism, AnHui Provincial Hospital, HeFei, Anhui, China
    • ,
  • Weiping Jia

      Affiliations

    • Shanghai Diabetic Institute, Shanghai Jiaotong University Affiliated No. 6 People Hospital, 600 Yishan Road, Shanghai 200233, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 21 64088466; fax: +86 21 64519943.

Received 19 February 2006 ,Accepted 3 July 2006.

References 

  1. Saad MF, Kmowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH. A two-step model for development of non-insulin-dependent diabetes. Am. J. Med. 1991;90:229–235(Abstract)
  2. Ilkova H, Glaser B, Tunckale A, Bagriacik N, Cerasi E. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diab. Care. 1997;20:1353–1356
  3. Zhu F, Ji L, Han X, Zhu Y, Zhang H, Zhou X, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Chin. J. Diab. 2003;11:5–9(in Chinese)
  4. Weng J, Li Y, Xu W, Chen X, Liao Z, Yao B, et al. The effect of long-term continuous subcutaneous insulin infusion treatment on beta-cell function in newly diagnosed type 2 diabetic patients. Chin. J. Diab. 2003;11:10–15(in Chinese)
  5. Li Y, Xu W, Liao Z, Yao B, Chen X, Huang Z, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of β-cell function. Diab. Care. 2004;27:2597–2602
  6. Ryan EA, Imes S, Wallace C. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diab. Care. 2004;27:1028–1032
  7. Donath MY, Storling J, Maedler K, Mandrup-Poulsen T. Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J. Mol. Med. 2003;81:455–470
  8. Tsiotra PC, Tsigos C, Raptis SA. TNFalpha and leptin inhibit basal and glucose-stimulated insulin secretion and gene transcription in the HIT-T15 pancreatic cells. Int. J. Obes. Relat. Metab. Disord. 2001;25:1018–1026
  9. Zhou HG, Li M, Zhang Y, Sen GX. Human β-cell destruction correlates with FAS expression on β-cell induced by IFN-γ and TNF-α. Chin. Immunol. J. 2000;16:666–668(in Chinese)
  10. Mellado-Gil JM, Aguilar-Diosdado M. High glucose potentiates cytokine- and streptozotocin-induced apoptosis of rat islet cells: effect on apoptosis-related genes. J. Endocrinol. 2004;183:155–162
  11. Kharroubi I, Ladrière L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL. Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology. 2004;145:5087–5096
  12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  13. Del Prato S, Marchetti P. Targeting insulin resistance and beta-cell dysfunction: the role of thiazolidinediones. Diab. Technol. Ther. 2004;6:719–731
  14. Stumvoll M, Goldstein BJ, Van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365:1333–1346
  15. Weyer C, Tataranni PA, Bogardus C, Pratley RE. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diab. Care. 2001;24:89–94
  16. Haffner SM, Miettinen H, Gaskill SP, Stern MP. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-American. Diabetes. 1995;44:1386–1391
  17. Leahy JL, Bonner-Weir S, Weir GC. β-Cell dysfunction induced by chronic hyperglycemia: current ideas on mechanism of impaired glucose-induced insulin secretion. Diab. Care. 1992;15:442–455
  18. Yoshikawa H, Tajiri H, Sako Y, Hashimoto T, Umeda F, Nawata H. Effect of free acids on β-cell function: a possible involvement of peroxisome proliferators-activated receptors α or pancreatic/duodenal homeobox. Metabolism. 2001;50:613–618
  19. Grishko V, Rachek L, Musiyenko S, Ledoux SP, Wilson GL. Involvement of mtDNA damage in free fatty acid-induced apoptosis. Free Radic. Biol. Med. 2005;38:755–762
  20. Furukawa H, Carroll RJ, Swift HH, Steiner DF. Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertase 2 and 3 in the pancreatic β-cell line MIN6. Diabetes. 1999;48:1395–1401
  21. Gwozdziewiczova S, Lichnovska R, Yahia RB, Chlup R, Hrebicek J. TNF-alpha in the development of insulin resistance and other disorders in metabolic syndrome. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 2005;149:109–117
  22. Winkler G, Salamon F, Harmos G, Salamon D, Speer G, Szekeres O, et al. Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity. Diab. Res. Clin. Pract. 1998;42:169–174
  23. Morohoshi M, Fujisawa K, Uchimura I, Numano F. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes. 1996;45:954–959
  24. Esposito K, Nappo E, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentration are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067–2072
  25. Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 2005;25:2062–2068
  26. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology. 2004;40:185–194
  27. Long SD, Pekala PH. Lipid mediators of insulin resistance: ceramide signaling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes. Biochem. J. 1996;319:179–184
  28. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. J. Clin. Invest. 1994;94:1543–1549
  29. Miura A, Ishizuka T, Kanoh Y, Ishizawa M, Itaya S, Kimura M. Effect of tumor necrosis TNF-α on insulin signal transduction in rat adipocytes: relation to PKC b and c translocation. Biochim. Biophys. Acta. 1999;1449:227–238
  30. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis TNF-α: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91

PII: S0168-8227(06)00298-1

doi: 10.1016/j.diabres.2006.07.001

Diabetes Research and Clinical Practice
Volume 75, Issue 3 , Pages 327-332 , March 2007

Article Tools

* Image Usage & Resolution